003017 大洋生物
等待开盘 02-09 09:30:00
资讯
新帖
简况
股市必读:大洋生物(003017)1月23日董秘有最新回复
证券之星 · 01-26
股市必读:大洋生物(003017)1月23日董秘有最新回复
大洋生物(003017)披露使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告,1月23日股价上涨0.22%
证券之星 · 01-23
大洋生物(003017)披露使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告,1月23日股价上涨0.22%
大洋生物:参股公司主营石墨基高纯陶瓷产品
证券之星 · 01-23
大洋生物:参股公司主营石墨基高纯陶瓷产品
大洋生物:浙江芯之纯生产的的高纯陶瓷材料,可以应用于芯片制造设备的零部件
证券之星 · 01-23
大洋生物:浙江芯之纯生产的的高纯陶瓷材料,可以应用于芯片制造设备的零部件
大洋生物:芯之纯产品仍在验证过程中
证券之星 · 01-20
大洋生物:芯之纯产品仍在验证过程中
大洋生物:基于技术优势新建PEEK项目
证券之星 · 01-20
大洋生物:基于技术优势新建PEEK项目
净利或将破亿!大洋生物跨界PEEK材料押注未来十年
中金财经 · 01-14
净利或将破亿!大洋生物跨界PEEK材料押注未来十年
股市必读:大洋生物(003017)1月12日董秘有最新回复
证券之星 · 01-13
股市必读:大洋生物(003017)1月12日董秘有最新回复
大洋生物:浙江芯之纯与珂玛科技同属半导体设备零部件制造领域
证券之星 · 01-12
大洋生物:浙江芯之纯与珂玛科技同属半导体设备零部件制造领域
大洋生物:浙江芯之纯设计产能为年产约4万件高纯陶瓷产品
证券之星 · 01-12
大洋生物:浙江芯之纯设计产能为年产约4万件高纯陶瓷产品
大洋生物(003017)披露使用部分闲置募集资金进行现金管理进展,1月7日股价下跌1.05%
证券之星 · 01-07
大洋生物(003017)披露使用部分闲置募集资金进行现金管理进展,1月7日股价下跌1.05%
大洋生物:芯之纯已进入试生产阶段
证券之星 · 01-06
大洋生物:芯之纯已进入试生产阶段
大洋生物(003017)披露2025年年度业绩预告,1月5日股价上涨10.01%
证券之星 · 01-05
大洋生物(003017)披露2025年年度业绩预告,1月5日股价上涨10.01%
异动快报:大洋生物(003017)1月5日10点18分触及涨停板
中金财经 · 01-05
异动快报:大洋生物(003017)1月5日10点18分触及涨停板
大洋生物:预计2025年全年归属净利润盈利9600万元至1.1亿元
证券之星 · 01-04
大洋生物:预计2025年全年归属净利润盈利9600万元至1.1亿元
每周股票复盘:大洋生物(003017)完成募资金专户销户
证券之星 · 01-03
每周股票复盘:大洋生物(003017)完成募资金专户销户
大洋生物(003017)披露关于部分募集资金专用账户销户的公告,12月30日股价上涨1.34%
证券之星 · 2025-12-30
大洋生物(003017)披露关于部分募集资金专用账户销户的公告,12月30日股价上涨1.34%
12月19日大洋生物发布公告,股东减持4.01万股
证券之星 · 2025-12-19
12月19日大洋生物发布公告,股东减持4.01万股
大洋生物(003017)披露合计持股5%以上股东减持股份的预披露公告,12月18日股价上涨1.07%
证券之星 · 2025-12-18
大洋生物(003017)披露合计持股5%以上股东减持股份的预披露公告,12月18日股价上涨1.07%
大洋生物最新公告:股东汪贤高拟减持不超0.68%股份
证券之星 · 2025-12-17
大洋生物最新公告:股东汪贤高拟减持不超0.68%股份
加载更多
公司概况
公司名称:
浙江大洋生物科技集团股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2020-10-26
主营业务:
浙江大洋生物科技集团股份有限公司的主营业务是无机盐、兽用原料药等化学原料产品的生产和销售。公司的主要产品是无机盐产品、兽用原料药和含氟精细化学品。公司为国家级高新技术企业、国家知识产权优势企业、国家级专精特新“小巨人”企业,浙江省专利示范企业,建有国家级博士后工作站、两个省级高新技术研究开发中心、省级企业技术中心和浙江省大洋科技钾盐研究院;先后主持或参与起草国家标准5项,行业标准3项,团体标准1项,覆盖主生产线各主要产品;截至2025年6月30日,公司拥有有效发明专利51项,实用新型专利21项,在国内外核心学术期刊发表论文30余篇,在生产过程中降低产品的原料单耗等研究方面有显著成果,且有效提升了公司在产品质量、环境保护、节能减排、安全生产等各方面的能力。
发行价格:
28.85
{"stockData":{"symbol":"003017","market":"SZ","secType":"STK","nameCN":"大洋生物","latestPrice":32.44,"timestamp":1770600567000,"preClose":32.16,"halted":0,"volume":15700,"delay":0,"changeRate":0.0087,"floatShares":69288000,"shares":84000000,"eps":1.1014,"marketStatus":"等待开盘","change":0.28,"latestTime":"02-09 09:30:00","open":32.44,"high":32.44,"low":32.44,"amount":509300,"amplitude":0,"askPrice":32.45,"askSize":15,"bidPrice":32.44,"bidSize":2,"shortable":0,"etf":0,"ttmEps":1.1014,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":7,"adr":0,"adjPreClose":32.16,"symbolType":"stock","openAndCloseTimeList":[[1770600600000,1770607800000],[1770613200000,1770620400000]],"highLimit":35.38,"lowLimit":28.94,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":84000000,"isCdr":false,"pbRate":2.46,"roa":"--","peRate":29.453423,"roe":"7.42%","epsLYR":0.7822,"committee":0.81405,"marketValue":2725000000,"turnoverRate":0.0002,"status":0,"floatMarketCap":2248000000},"requestUrl":"/m/hq/s/003017","defaultTab":"news","newsList":[{"id":"2606265171","title":"股市必读:大洋生物(003017)1月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606265171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606265171?lang=zh_cn&edition=full","pubTime":"2026-01-26 03:27","pubTimestamp":1769369231,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,大洋生物报收于32.5元,上涨0.22%,换手率3.9%,成交量2.71万手,成交额8771.6万元。公司公告汇总关于使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告浙江大洋生物科技集团股份有限公司于2026年1月21日赎回子公司福建舜跃在杭州银行购买的两笔单位大额存单理财产品,合计赎回本金2,000.00万元,获得投资收益分别为24.10万元和24.58万元,资金已全额返还至募集资金专户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2605409955","title":"大洋生物(003017)披露使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告,1月23日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605409955","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605409955?lang=zh_cn&edition=full","pubTime":"2026-01-23 23:08","pubTimestamp":1769180896,"startTime":"0","endTime":"0","summary":"近日,浙江大洋生物科技集团股份有限公司披露《关于使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告》。同日,公司继续使用闲置募集资金1,000.00万元购买杭州银行单位大额存单多元服务G02期2年产品,另一笔1,000.00万元购买G30期2年产品,预期年化收益率分别为2.55%和2.60%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2605420164","title":"大洋生物:参股公司主营石墨基高纯陶瓷产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2605420164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605420164?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:39","pubTimestamp":1769157546,"startTime":"0","endTime":"0","summary":"证券之星消息,大洋生物01月23日在投资者关系平台上答复投资者关心的问题。谢谢大洋生物回复:您好,感谢您对公司的关注。公司参股的浙江芯之纯半导体材料有限公司主要业务是生产制造石墨基高纯陶瓷产品,可以应用于半导体设备以及LED等外延设备的零部件方面。其技术优势在于拥有自主研发的核心生产设备及产品工艺配方,其生产的产品属于第三代半导体碳化硅材料领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300025316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2605420112","title":"大洋生物:浙江芯之纯生产的的高纯陶瓷材料,可以应用于芯片制造设备的零部件","url":"https://stock-news.laohu8.com/highlight/detail?id=2605420112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605420112?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:36","pubTimestamp":1769157374,"startTime":"0","endTime":"0","summary":"证券之星消息,大洋生物(003017)01月23日在投资者关系平台上答复投资者关心的问题。投资者提问:芯之纯的半导体零部件产品直接接触晶圆,是否能用于存储芯片制造。?大洋生物回复:您好,感谢您对公司的关注。浙江芯之纯生产的的高纯陶瓷材料,可以应用于芯片制造设备的零部件,属于芯片制造业上游供应商。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300024954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159813","003017","BK0229"],"gpt_icon":0},{"id":"2604151034","title":"大洋生物:芯之纯产品仍在验证过程中","url":"https://stock-news.laohu8.com/highlight/detail?id=2604151034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604151034?lang=zh_cn&edition=full","pubTime":"2026-01-20 08:38","pubTimestamp":1768869484,"startTime":"0","endTime":"0","summary":"证券之星消息,大洋生物(003017)01月19日在投资者关系平台上答复投资者关心的问题。投资者提问:浙江芯之纯目前半导体陶瓷零部件送样进度如何?建议让芯之纯开通公众号、官网,提升芯之纯品牌力,现在连个公众号官网都没有也不利于芯之纯业务拓展。大洋生物回复:您好,芯之纯生产产品直接接触晶圆,验证周期较长,目前还在验证过程中。我们已收到您的建议并反馈给相关人员,感谢您对公司及浙江芯之纯的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000005358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2604510871","title":"大洋生物:基于技术优势新建PEEK项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2604510871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604510871?lang=zh_cn&edition=full","pubTime":"2026-01-20 08:38","pubTimestamp":1768869483,"startTime":"0","endTime":"0","summary":"证券之星消息,大洋生物01月19日在投资者关系平台上答复投资者关心的问题。投资者提问:公司拟投资1.9325亿元新建年产2000吨特种高分子材料聚醚醚酮及关键中间体4,4′–二氟二苯甲酮等项目。PEEK材料作为特种工程塑料中的“黄金材料”,公司是否有足够的技术实力呢?公司新建PEEK及关键中间体项目是是基于自身技术优势的考量。公司将持续坚守创新引领、质量至上的发展理念,聚焦氟化产品高质量发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000005356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2603085693","title":"净利或将破亿!大洋生物跨界PEEK材料押注未来十年","url":"https://stock-news.laohu8.com/highlight/detail?id=2603085693","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603085693?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:10","pubTimestamp":1768378201,"startTime":"0","endTime":"0","summary":"在主营业务稳健发展的同时,大洋生物在2025年底公布了PEEK材料的相关项目投资,公司有意借助PEEK材料的广阔发展前景,实现利润的进一步增长。根据预告,其2025年净利润有望破亿,创上市以来新高。这就给大洋生物跨界PEEK材料领域提供了契机。在这其中,最具优势的就是大洋生物能够自产DFBP,使PEEK原料成本大幅降低,打破国际中间体供应商的价格垄断。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/14/20260114494783.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/14/20260114494783.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260114/31941562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2603540188","title":"股市必读:大洋生物(003017)1月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603540188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603540188?lang=zh_cn&edition=full","pubTime":"2026-01-13 01:59","pubTimestamp":1768240748,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘,大洋生物报收于31.31元,上涨0.06%,换手率4.98%,成交量3.45万手,成交额1.08亿元。董秘最新回复投资者: 请问浙江芯之纯是否和珂玛科技属于同类公司?浙江芯之纯与珂玛科技同属半导体设备零部件制造领域,均为产业链上游配套企业。浙江芯之纯设计产能为年产约4万件高纯陶瓷产品,完全达产后预计产值约3亿元。当日关注点来自交易信息汇总:1月12日主力资金净流出1077.42万元,散户资金净流入1291.7万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300001555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2602597671","title":"大洋生物:浙江芯之纯与珂玛科技同属半导体设备零部件制造领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2602597671","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602597671?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:42","pubTimestamp":1768207327,"startTime":"0","endTime":"0","summary":"证券之星消息,大洋生物(003017)01月12日在投资者关系平台上答复投资者关心的问题。投资者提问:请问浙江芯之纯是否和珂玛科技属于同类公司?大洋生物回复:您好!感谢您对公司的关注。浙江芯之纯与珂玛科技同属半导体设备零部件制造领域,均为产业链上游配套企业。浙江芯之纯专注于石墨基碳化硅半导体设备零件制造。行业分类及细分赛道界定可能随企业业务拓展、技术迭代发生变化,敬请投资者注意投资风险。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200020861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","159582","BK0229","BK0214","301611"],"gpt_icon":0},{"id":"2602597675","title":"大洋生物:浙江芯之纯设计产能为年产约4万件高纯陶瓷产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2602597675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602597675?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:39","pubTimestamp":1768207151,"startTime":"0","endTime":"0","summary":"证券之星消息,大洋生物(003017)01月12日在投资者关系平台上答复投资者关心的问题。投资者提问:芯之纯主要生产半导体级高纯陶瓷产品,请问设计产能、预计产值是多少?大洋生物回复:您好!感谢您对公司的关注。浙江芯之纯设计产能为年产约4万件高纯陶瓷产品,完全达产后预计产值约3亿元。项目实际产能与产值受多方面因素影响,敬请投资者注意投资风险。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200020516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2601801272","title":"大洋生物(003017)披露使用部分闲置募集资金进行现金管理进展,1月7日股价下跌1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801272?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:39","pubTimestamp":1767796757,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘,大洋生物报收于31.07元,较前一交易日下跌1.05%,最新总市值为26.1亿元。公司近日发布公告称,浙江大洋生物科技集团股份有限公司于2026年1月6日赎回子公司福建舜跃在杭州银行购买的1,000.00万元单位大额存单理财产品,获得理财收益25.36万元,本金及收益已全部存入募集资金专户。同日,福建舜跃继续使用闲置募集资金1,000.00万元购买杭州银行单位大额存单多元服务G02期2年产品,预期年化收益率2.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700039180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2601859385","title":"大洋生物:芯之纯已进入试生产阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2601859385","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601859385?lang=zh_cn&edition=full","pubTime":"2026-01-06 08:48","pubTimestamp":1767660491,"startTime":"0","endTime":"0","summary":"证券之星消息,大洋生物(003017)01月05日在投资者关系平台上答复投资者关心的问题。投资者提问:浙江芯之纯现在进展如何?有产品落地吗?主要是什么产品?主要客户是哪些?大洋生物回复:浙江芯之纯半导体材料有限公司已完成项目建设,现处于试生产阶段,并已有部分产品开始送样质检。芯之纯主要生产半导体级高纯陶瓷产品,可应用于半导体设备和LED外延炉的核心零部件。主要服务于半导体设备生产制造类型客户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600006957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2601002099","title":"大洋生物(003017)披露2025年年度业绩预告,1月5日股价上涨10.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601002099","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601002099?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:43","pubTimestamp":1767606189,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘,大洋生物报收于32.85元,较前一交易日上涨10.01%,最新总市值为27.59亿元。该股当日开盘31.21元,最高32.85元,最低30.05元,成交额达2.88亿元,换手率为12.93%。公司近日发布公告,披露2025年年度业绩预告。本次业绩预告未经会计师事务所预审计,最终数据以2025年年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500025812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2601794540","title":"异动快报:大洋生物(003017)1月5日10点18分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601794540","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601794540?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:44","pubTimestamp":1767581054,"startTime":"0","endTime":"0","summary":"证券之星1月5日盘中消息,10点18分大洋生物触及涨停板。其所属行业化学原料目前上涨。领涨股为振华股份。该股为医药,动物保健,化学原料药概念热股,当日医药概念上涨1.86%,动物保健概念上涨1.82%,化学原料药概念上涨1.75%。12月31日的资金流向数据方面,主力资金净流出315.91万元,占总成交额7.11%,游资资金净流入254.95万元,占总成交额5.74%,散户资金净流入60.96万元,占总成交额1.37%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/05/20260105844914.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/05/20260105844914.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260105/31914209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2600804179","title":"大洋生物:预计2025年全年归属净利润盈利9600万元至1.1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600804179","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600804179?lang=zh_cn&edition=full","pubTime":"2026-01-04 16:00","pubTimestamp":1767513646,"startTime":"0","endTime":"0","summary":"证券之星消息,大洋生物发布业绩预告,预计2025年全年归属净利润盈利9600万元至1.1亿元。公告中解释本次业绩变动的原因为:本报告期内,归属于上市公司股东的净利润较上年同期上升50.60%-72.56%。业绩增长的主要原因系公司核心产品碳酸钾及兽用原料药业务实现量价齐升的良好发展态势。量价叠加推动产品毛利率同比上升,成为公司净利润增长的核心支撑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010400001366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017"],"gpt_icon":0},{"id":"2600406067","title":"每周股票复盘:大洋生物(003017)完成募资金专户销户","url":"https://stock-news.laohu8.com/highlight/detail?id=2600406067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600406067?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:41","pubTimestamp":1767382870,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,大洋生物报收于29.86元,较上周的29.56元上涨1.01%。本周,大洋生物12月30日盘中最高价报30.47元。大洋生物当前最新总市值25.08亿元,在化学原料板块市值排名57/57,在两市A股市值排名4861/5181。公司公告汇总浙江大洋生物科技集团股份有限公司因广发银行杭州分行募集资金专户资金已使用完毕,将账户余额0.00元及利息0.05元转入其他募集资金账户,已完成该专户销户手续,相关监管协议终止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2595169718","title":"大洋生物(003017)披露关于部分募集资金专用账户销户的公告,12月30日股价上涨1.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595169718","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595169718?lang=zh_cn&edition=full","pubTime":"2025-12-30 22:23","pubTimestamp":1767104597,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘,大洋生物报收于30.19元,较前一交易日上涨1.34%,最新总市值为25.36亿元。该股当日开盘29.7元,最高30.47元,最低29.49元,成交额达5638.31万元,换手率为2.72%。公司近日发布公告称,浙江大洋生物科技集团股份有限公司因广发银行杭州分行募集资金专户资金已使用完毕,将账户余额0.00元及利息0.05元转入其他募集资金账户,已完成该专户销户手续,相关监管协议终止。截至2025年12月29日,公司募集资金专户存储余额合计80.22万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000044261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2592692021","title":"12月19日大洋生物发布公告,股东减持4.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592692021","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592692021?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:01","pubTimestamp":1766145716,"startTime":"0","endTime":"0","summary":"证券之星消息,12月19日大洋生物发布公告《大洋生物:关于实际控制人的一致行动人减持股份计划期限届满暨实施情况的公告》,其股东陈寿良于2025年10月27日至2025年12月18日间合计减持4.01万股,占公司目前总股本的0.0477%,变动期间该股股价下跌13.92%,截止12月18日收盘报29.24元。股东增减持详情见下表:根据大洋生物2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900034257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2592717579","title":"大洋生物(003017)披露合计持股5%以上股东减持股份的预披露公告,12月18日股价上涨1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592717579","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592717579?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:47","pubTimestamp":1766051256,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘,大洋生物报收于29.24元,较前一交易日上涨1.07%,最新总市值为24.56亿元。该股当日开盘28.67元,最高29.51元,最低28.38元,成交额达5650.7万元,换手率为2.81%。公司近日发布公告称,持股5%以上股东汪贤高先生计划自2026年1月12日至2026年4月11日,通过集中竞价方式减持公司股份不超过570,000股,占公司总股本的0.68%。截至公告日,汪贤高持有公司股份648,482股,占总股本0.77%,与一致行动人合计持股5.57%。本次减持不会导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800027048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2592533992","title":"大洋生物最新公告:股东汪贤高拟减持不超0.68%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2592533992","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592533992?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:00","pubTimestamp":1765972815,"startTime":"0","endTime":"0","summary":"大洋生物(003017.SZ)公告称,股东汪贤高因自身资金需求,计划以集中竞价方式减持公司股份不超过57万股,占公司总股本的0.68%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700034608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770600570676,"stockEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":0.0351},{"period":"3month","weight":-0.0111},{"period":"6month","weight":0.0413},{"period":"1year","weight":0.5927},{"period":"ytd","weight":0.077}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江大洋生物科技集团股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"10049人(较上一季度减少93.72%)","perCapita":"6895股","listingDate":"2020-10-26","address":"浙江省杭州市建德市大洋镇朝阳路22号","registeredCapital":"8400万元","survey":" 浙江大洋生物科技集团股份有限公司的主营业务是无机盐、兽用原料药等化学原料产品的生产和销售。公司的主要产品是无机盐产品、兽用原料药和含氟精细化学品。公司为国家级高新技术企业、国家知识产权优势企业、国家级专精特新“小巨人”企业,浙江省专利示范企业,建有国家级博士后工作站、两个省级高新技术研究开发中心、省级企业技术中心和浙江省大洋科技钾盐研究院;先后主持或参与起草国家标准5项,行业标准3项,团体标准1项,覆盖主生产线各主要产品;截至2025年6月30日,公司拥有有效发明专利51项,实用新型专利21项,在国内外核心学术期刊发表论文30余篇,在生产过程中降低产品的原料单耗等研究方面有显著成果,且有效提升了公司在产品质量、环境保护、节能减排、安全生产等各方面的能力。","listedPrice":28.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"大洋生物(003017)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供大洋生物(003017)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"大洋生物,003017,大洋生物股票,大洋生物股票老虎,大洋生物股票老虎国际,大洋生物行情,大洋生物股票行情,大洋生物股价,大洋生物股市,大洋生物股票价格,大洋生物股票交易,大洋生物股票购买,大洋生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"大洋生物(003017)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供大洋生物(003017)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}